Skip to main content

Advertisement

Log in

Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report

  • Case Report
  • Published:
Child's Nervous System Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. de Buy M, Wenniger L, Terpstra V, Beuers U (2010) Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 27(1):24–31

    Article  Google Scholar 

  2. Rooks JB, Ory HW, Ishak KG et al (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242(7):644–648

    Article  PubMed  CAS  Google Scholar 

  3. Socas L, Zumbado M, Pérez-Luzardo O et al (2005) Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 39(5):27

    Article  Google Scholar 

  4. Oshita A, Itamoto T, Amano H et al (2008) Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia. J Hepatobiliary Pancreat Surg 15(2):200–203

    Article  PubMed  Google Scholar 

  5. Resnick MB, Kozakewich HP, Perez-Atayde AR (1995) Hepatic adenoma in the pediatric age group. Clinicopathological observations and assessment of cell proliferative activity. Am J Surg Pathol 19(10):1181–1190

    Article  PubMed  CAS  Google Scholar 

  6. Levy RH, Mattson RH, Meldrum BS et al (2002) Antiepileptic drugs, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 528–540

    Google Scholar 

  7. Clemmesen J, Hjalgrim-Jensen S (1978) Is phenobarbital carcinogenic? A follow-up of 8078 epileptics. Ecotoxicol Environ Saf 1(4):457–470

    Article  PubMed  CAS  Google Scholar 

  8. Clemmesen J, Hjalgrim-Jensen S (1981) Does phenobarbital cause intracranial tumors? A follow-up through 35 years. Ecotoxicol Environ Saf 5(2):255–260

    Article  PubMed  CAS  Google Scholar 

  9. White SJ, McLean AE, Howland C (1979) Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy. Lancet 2(8140):458–461

    Article  PubMed  CAS  Google Scholar 

  10. Olsen JH, Boice JD Jr, Jensen JP, Fraumeni JF Jr (1989) Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 81(10):803–808

    Article  PubMed  CAS  Google Scholar 

  11. Olsen J, Wallin H, Boice JD Jr et al (1993) Phenobarbital, drug metabolism, and human cancer. Cancer Epidemiol Biomarkers Prev 2(5):449–452

    PubMed  CAS  Google Scholar 

  12. Lamminpää A, Pukkala E, Teppo L, Neuvonen PJ (2002) Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur J Clin Pharmacol 58(2):137–141

    Article  PubMed  Google Scholar 

  13. Peraino C, Fry RJ, Staffeldt E (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res 31(10):1506–1512

    PubMed  CAS  Google Scholar 

  14. Driver HE, McLean AE (1986) Dose–response relationships for initiation of rat liver tumours by diethylnitrosamine and promotion by phenobarbitone or alcohol. Food Chem Toxicol 24(3):241–245

    Article  PubMed  CAS  Google Scholar 

  15. Diwan BA, Rice JM, Nims RW et al (1988) P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats. Cancer Res 48(9):2492–2497

    PubMed  CAS  Google Scholar 

  16. Singh G, Driever PH, Sander JW (2005) Cancer risk in people with epilepsy: the role of antiepileptic drugs. Brain 128(Pt 1):7–17

    PubMed  Google Scholar 

  17. Lautz TB, Finegold MJ, Chin AC, Superina RA (2008) Giant hepatic adenoma with atypical features in a patient on oxcarbazepine therapy. J Pediatr Surg 43(4):751–754

    Article  PubMed  CAS  Google Scholar 

  18. Seki A, Inoue T, Maegaki Y et al (2006) Polycystic ovary syndrome and hepatocellular adenoma related to long-term use of sodium valproate in a young woman. No To Hattatsu 38(3):205–208

    PubMed  Google Scholar 

  19. Tazawa K, Yasuda M, Ohtani Y et al (1999) Multiple hepatocellular adenomas associated with long-term carbamazepine. Histopathology 35(1):92–94

    Article  PubMed  CAS  Google Scholar 

  20. Rignall B, Braeuning A, Buchmann A, Schwarz M (2011) Tumor formation in liver of conditional β-catenin-deficient mice exposed to a diethylnitrosamine/phenobarbital tumor promotion regimen. Carcinogenesis 32(1):52–57

    Article  PubMed  CAS  Google Scholar 

  21. Phillips JM, Goodman JI (2009) Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors. Toxicol Sci 108(2):273–289

    Article  PubMed  CAS  Google Scholar 

  22. Phillips JM, Burgoon LD, Goodman JI (2009) Phenobarbital elicits unique, early changes in the expression of hepatic genes that affect critical pathways in tumor-prone B6C3F1 mice. Toxicol Sci 109(2):193–205

    Article  PubMed  CAS  Google Scholar 

  23. Klaunig JE (1993) Selective induction of DNA synthesis in mouse preneoplastic and neoplastic hepatic lesions after exposure to phenobarbital. Environ Health Perspect 101(Suppl 5):235–239

    Article  PubMed  CAS  Google Scholar 

  24. Hyman GA, Sommers SC (1966) The development of Hodgkin's disease and lymphoma during anticonvulsant therapy. Blood 28(3):416–427

    PubMed  CAS  Google Scholar 

  25. Kruger GR, Harris D (1972) Is phenytoin carcinogenic? Lancet 1(7745):323

    Article  PubMed  CAS  Google Scholar 

  26. Vázquez JJ, Marigil MA (1989) Liver-cell adenoma in an epileptic man on barbiturates. Histol Histopathol 4(3):301–303

    PubMed  Google Scholar 

  27. Ferko A, Bedrna J, Nozicka J (2003) Pigmented hepatocellular adenoma of the liver caused by long-term use of phenobarbital. Rozhl Chir 82(4):192–195

    PubMed  CAS  Google Scholar 

  28. Warner KA, Fernstrom MJ, Ruch RJ (2003) Inhibition of mouse hepatocyte gap junctional intercellular communication by phenobarbital correlates with strain-specific hepatocarcinogenesis. Toxicol Sci 71(2):190–197

    Article  PubMed  CAS  Google Scholar 

  29. Michelucci R (2006) Optimizing therapy of seizures in neurosurgery. Neurology 67(12 Suppl 4):S14–S18

    Article  PubMed  Google Scholar 

Download references

Author contributions

The authors of this case report actively participated in patient care and post-discharge follow-up.

Declaration of conflicting interests

The authors declared no potential conflicts of interest with respect to the authorship and/or publication of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Caterina Cerminara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerminara, C., Bagnolo, V., De Leonardis, F. et al. Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report. Childs Nerv Syst 28, 939–941 (2012). https://doi.org/10.1007/s00381-011-1636-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-011-1636-1

Keywords

Navigation